Stock Updates

How has Eli Lilly and Company:(NYSE:LLY) performed recently?

Eli Lilly and Company (NYSE: LLY) is a large market cap stock with a market cap of 88925.48. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 34.58, a forward P/E of 19.61 and EPS of 2.32. At a stock price of 80.37 (0.19%) it has a dividend yield of 2.54%.

EPS growth for the last five years have been -13.20%, more recently this last year it has grown by 1.60%. The next year growth is going to be about 13.99% and more long-term 13.06% after five years. EPS growth quarter over quarter is 25.10%. Sales growth for the past five years have been -2.90% and sales growth quarter over quarter is 8.60%.

For performance, Eli Lilly and Company the past week has seen a gain of -1.02%. For the last month performance for Eli Lilly and Company is 0.18%. While the last quarter is 5.77% and half year, 14.03%. Finally for the year, performance is -0.81%.

The 52-week high for Eli Lilly and Company, is at -11.14%, and for the 52-week low it comes to a value of 19.95%. The 20-day simple moving average is 3.09% and 4.27% for the 200-day simple moving average.

Volatility for the week is at 1.45%, and for the month it is 1.32%. Eli Lilly and Company, has a target price of 96.81.

In terms of debt, long term debt/equity is 0.59, and for total debt/equity Eli Lilly and Company has 0.64. The gross margin is 73.70%, while operating margin is 14.60%, the profit margin is 12.00%. The current ratio is 1.5 and the quick ratio is 1.1.

Insider ownership is at 11.40%, with instituitional ownership at 77.40%. Eli Lilly and Company has a payout ratio of 91.20%. With the total shares outstanding coming to 1108.52. The shares float is 1101.58, with the float short at 0.77%, with short ratio coming to 2.06.

In terms of returns, the return on assets see Eli Lilly and Company, get 6.90%, with its returns on investment at 9.50%. Return on equity is 16.60%. So will the investors see the target price of 96.81, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment